1. Home
  2. AMPH vs NAVI Comparison

AMPH vs NAVI Comparison

Compare AMPH & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.18

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$8.46

Market Cap

802.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
NAVI
Founded
1996
1973
Country
United States
United States
Employees
N/A
670
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
971.8M
802.7M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
NAVI
Price
$18.18
$8.46
Analyst Decision
Buy
Sell
Analyst Count
8
6
Target Price
$28.38
$10.00
AVG Volume (30 Days)
644.5K
857.1K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
6.73%
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$719,887,000.00
N/A
Revenue This Year
$6.90
$76.23
Revenue Next Year
$4.64
$15.73
P/E Ratio
$130.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.65
$7.80
52 Week High
$31.26
$16.07

Technical Indicators

Market Signals
Indicator
AMPH
NAVI
Relative Strength Index (RSI) 40.00 48.48
Support Level $17.03 $7.83
Resistance Level $20.08 $8.79
Average True Range (ATR) 0.81 0.28
MACD -0.21 -0.02
Stochastic Oscillator 19.16 51.26

Price Performance

Historical Comparison
AMPH
NAVI

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

Share on Social Networks: